Promethean, a leading global education technology company and brand owned by Mynd.ai, Inc. , won this year's Tech & Learning Awards of Excellence: Back to School 2024 in the Primary category from Tech ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Merck (NYSE:MRK) with a Market Perform ...

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional ...

(RTTNews) - Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development collaboration to evaluate the combination of Exelixis ...

In a report released yesterday, Chris Shibutani from Goldman Sachs maintained a Sell rating on Exelixis (EXEL – Research Report). The ...

German science and technology company Merck lowered mid-term targets for its Life Sciences and Healthcare businesses, ...

EXEL is set to evaluate investigational zanzalintinib in combination with Merck;s Keytruda (pembrolizumab) and Welireg in head and neck cancer and renal cell carcinoma, respectively. ALAMEDA ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The U.S. government's Biomedical Advanced Research and Development Authority (BARDA) selected opaganib for joint development & funding as a medical countermeasure (MCM) to treat Ebola virus disease ...